Clinical Trial Update: A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents [Phase 4]

View source ↗

Summary

A Phase 4 randomized study evaluating immunogenicity and safety of co-administering HPV and Tdap vaccines with MenACWY in adolescents, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• Gardasil (human papillomavirus vaccine)
• MenACWY vaccine (Menveo) (meningococcal group A, C, W, and Y conjugate vaccine)
• Tdap vaccine (Diphtheria, tetanus, and pertussis vaccine (Tdap))

Snippet

Sponsor: Novartis | Conditions: Meningococcal Meningitis | Phase 4 | Status: COMPLETED | Results posted: 2014-02-14